Stocks · News reference

Reported Earlier, Outlook Therapeutics Prices $55.0M Offering Of 55,555,556 Shares And Warrants At $0.99 Combined Price Per Share

Aug 13, 2026, 7:10 AMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARAug 27, 2026, 8:11 PMSEC EDGAR
8-K filing — Outlook Therapeutics, Inc. (OTLK)
Filed: 2026-08-27 AccNo: 0001104659-26-102446 Size: 366 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Read original at edgar
OTLK
BenzingaAug 27, 2026, 8:07 PMBenzinga Newsdesk
Outlook Therapeutics Announces Appointment Of Kevin Lundquist As CFO Effective September 1
Read original at benzinga
OTLK
BenzingaAug 14, 2026, 5:19 PMBenzinga Newsdesk
BTIG Reiterates Buy on Outlook Therapeutics, Maintains $4 Price Target
BTIG analyst Julian Harrison reiterates Outlook Therapeutics (NASDAQ:OTLK) with a Buy and maintains $4 price target.
Read original at benzinga
OTLK
BenzingaAug 14, 2026, 5:06 PMBenzinga Insights
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular session. The company's market cap stands at $23.7 million. The company's, Q2 earnings came out yesterday.
Read original at benzinga
AKAN BEAT CAPR DARE ETON